Mr. Speaker, I really have some difficulty understanding what the hon. member is talking about because we have one of the most rigorous drug approval processes in the world. In fact, I think it is fair to say that this country is noted for the premium that it puts on the protection of Canadians' safety.
I also want to inform the hon. member that as part of our smart regulation initiative we are in the process of reviewing the timeliness of drug approvals. However I want to underscore for everyone that our first priority is always the health and safety of Canadians before any product is allowed on the market.